{"DataElement":{"publicId":"7331629","version":"1","preferredName":"Esophageal Neoplasm Pathologic Stage Grouping CPTAC Stage","preferredDefinition":"Stage group based on the combination of T, N, and M categories and relevant prognostic factors for the malignant neoplasm involving the esophagus.","longName":"7329968v1.0:7331798v1.0","context":"OCCPR","contextVersion":"1","DataElementConcept":{"publicId":"7329968","version":"1","preferredName":"Esophageal Neoplasm Pathologic Stage Grouping","preferredDefinition":"A benign or malignant neoplasm involving the esophagus._Caused by or altered by or manifesting disease or pathology._An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","longName":"7320536v1.0:2230144v1.0","context":"OCCPR","contextVersion":"1","ObjectClass":{"publicId":"7320536","version":"1","preferredName":"Esophageal Neoplasm","preferredDefinition":"A benign or malignant neoplasm involving the esophagus.","longName":"C3028","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Esophageal Neoplasm","conceptCode":"C3028","definition":"A benign or malignant neoplasm involving the esophagus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7A5EA99-87C0-4380-E053-4EBD850A1E30","latestVersionIndicator":"Yes","beginDate":"2020-06-09","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-06-09","modifiedBy":"ONEDATA","dateModified":"2020-06-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2230144","version":"1","preferredName":"Pathologic Stage Grouping","preferredDefinition":"Pathologic; caused by or altered by or manifesting disease or pathology.:Stage Grouping; an assessment based on the combined evaluation of the patient's T stage, M stage, and N stage. (caDSR)","longName":"C25610:C38027","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F752037A-4CCE-36A8-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-18","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-05-18","modifiedBy":"ONEDATA","dateModified":"2005-05-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7BE1F36-E102-305D-E053-4EBD850A79EB","latestVersionIndicator":"Yes","beginDate":"2020-06-10","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-06-10","modifiedBy":"KNABLEJ","dateModified":"2020-06-22","changeDescription":"6/22/20 jk Released per SME (NGM) review and approval email.  6/10/20 jk created for CPTAC ESCA Baseline CRF - generalized AJCC level.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7331798","version":"1","preferredName":"CPTAC ESCA Stage","preferredDefinition":"A national effort to accelerate the understanding of the molecular basis of cancer through the application of large-scale proteome and genome analysis, or proteogenomics._A benign or malignant neoplasm involving the esophagus._The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"7331798v1.0","context":"OCCPR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"20","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"IVB-SCC","valueDescription":"Pathologic Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8","ValueMeaning":{"publicId":"6438059","version":"1","preferredName":"Pathologic Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8","longName":"6438059","preferredDefinition":"Stage IVB includes: Any T, Any N, M1, Any G, Tumor location: Any. M1: Distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8","conceptCode":"C133542","definition":"Stage IVB includes: Any T, Any N, M1, Any G, Tumor location: Any. M1: Distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76A20948-D9BD-505B-E053-F662850A72D4","latestVersionIndicator":"Yes","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"ONEDATA","dateModified":"2018-09-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A80D0215-5C9C-755C-E053-4EBD850A27CB","beginDate":"2020-06-14","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-06-14","modifiedBy":"ONEDATA","dateModified":"2020-06-14","deletedIndicator":"No"},{"value":"IVA-SCC","valueDescription":"Pathologic Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8","ValueMeaning":{"publicId":"6438061","version":"1","preferredName":"Pathologic Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8","longName":"6438061","preferredDefinition":"Stage IVA includes: (T4a, N2, M0, Any G, Tumor location: Any); (T4b, N0-2, M0, Any G, Tumor location: Any); (Any T, N3, M0, Any G, Tumor location: Any). T4a: Tumor invades the pleura, pericardium, azygos vein, diaphragm, or peritoneum. T4b: Tumor invades other adjacent structures, such as the aorta, vertebral body, or airway. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. N3: Tumor with metastasis in seven or more regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8","conceptCode":"C133541","definition":"Stage IVA includes: (T4a, N2, M0, Any G, Tumor location: Any); (T4b, N0-2, M0, Any G, Tumor location: Any); (Any T, N3, M0, Any G, Tumor location: Any). T4a: Tumor invades the pleura, pericardium, azygos vein, diaphragm, or peritoneum. T4b: Tumor invades other adjacent structures, such as the aorta, vertebral body, or airway. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. N3: Tumor with metastasis in seven or more regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76A20948-D9E3-505B-E053-F662850A72D4","latestVersionIndicator":"Yes","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"ONEDATA","dateModified":"2018-09-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A80D0215-5CB0-755C-E053-4EBD850A27CB","beginDate":"2020-06-14","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-06-14","modifiedBy":"ONEDATA","dateModified":"2020-06-14","deletedIndicator":"No"},{"value":"IIIB-SCC","valueDescription":"Pathologic Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8","ValueMeaning":{"publicId":"6438063","version":"1","preferredName":"Pathologic Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8","longName":"6438063","preferredDefinition":"Stage IIIB includes: (T2, N2, M0, Any G, Tumor location: Any); (T3, N1-2, M0, Any G, Tumor location: Any); (T4a, N0-1, M0, Any G, Tumor location: Any). T2: Tumor invades the muscularis propria. T3: Tumor invades adventitia. T4a: Tumor invades the pleura, pericardium, azygos vein, diaphragm, or peritoneum. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8","conceptCode":"C133538","definition":"Stage IIIB includes: (T2, N2, M0, Any G, Tumor location: Any); (T3, N1-2, M0, Any G, Tumor location: Any); (T4a, N0-1, M0, Any G, Tumor location: Any). T2: Tumor invades the muscularis propria. T3: Tumor invades adventitia. T4a: Tumor invades the pleura, pericardium, azygos vein, diaphragm, or peritoneum. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76A20948-DA09-505B-E053-F662850A72D4","latestVersionIndicator":"Yes","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"ONEDATA","dateModified":"2018-09-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A80D0215-5CC4-755C-E053-4EBD850A27CB","beginDate":"2020-06-14","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-06-14","modifiedBy":"ONEDATA","dateModified":"2020-06-14","deletedIndicator":"No"},{"value":"IIIA-SCC","valueDescription":"Pathologic Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8","ValueMeaning":{"publicId":"6438065","version":"1","preferredName":"Pathologic Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8","longName":"6438065","preferredDefinition":"Stage IIIA includes: (T1, N2, M0, Any G, Tumor location: Any); (T2, N1, M0, Any G, Tumor location: Any). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8","conceptCode":"C133537","definition":"Stage IIIA includes: (T1, N2, M0, Any G, Tumor location: Any); (T2, N1, M0, Any G, Tumor location: Any). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76A20948-DA2F-505B-E053-F662850A72D4","latestVersionIndicator":"Yes","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"ONEDATA","dateModified":"2018-09-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A80D0215-5CD8-755C-E053-4EBD850A27CB","beginDate":"2020-06-14","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-06-14","modifiedBy":"ONEDATA","dateModified":"2020-06-14","deletedIndicator":"No"},{"value":"IIB-SCC","valueDescription":"Pathologic Stage IIB Esophageal Squamous Cell Carcinoma AJCC v8","ValueMeaning":{"publicId":"6438067","version":"1","preferredName":"Pathologic Stage IIB Esophageal Squamous Cell Carcinoma AJCC v8","longName":"6438067","preferredDefinition":"Stage IIB includes: (T3, N0, M0, G2-3, Tumor location: Upper/middle); (T3, N0, M0, GX, Tumor location: Any); (T3, N0, M0, Any G, Tumor location: Unknown); (T1, N1, M0, Any G, Tumor location: Any). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T3: Tumor invades adventitia. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. M0: No distant metastasis. GX: Grade cannot be assessed. G2: Moderately differentiated. G3: Poorly differentiated, undifferentiated (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic Stage IIB Esophageal Squamous Cell Carcinoma AJCC v8","conceptCode":"C133535","definition":"Stage IIB includes: (T3, N0, M0, G2-3, Tumor location: Upper/middle); (T3, N0, M0, GX, Tumor location: Any); (T3, N0, M0, Any G, Tumor location: Unknown); (T1, N1, M0, Any G, Tumor location: Any). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T3: Tumor invades adventitia. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. M0: No distant metastasis. GX: Grade cannot be assessed. G2: Moderately differentiated. G3: Poorly differentiated, undifferentiated (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76A20948-DA55-505B-E053-F662850A72D4","latestVersionIndicator":"Yes","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"ONEDATA","dateModified":"2018-09-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A80D0215-5CEC-755C-E053-4EBD850A27CB","beginDate":"2020-06-14","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-06-14","modifiedBy":"ONEDATA","dateModified":"2020-06-14","deletedIndicator":"No"},{"value":"IIA-SCC","valueDescription":"Pathologic Stage IIA Esophageal Squamous Cell Carcinoma AJCC v8","ValueMeaning":{"publicId":"6438069","version":"1","preferredName":"Pathologic Stage IIA Esophageal Squamous Cell Carcinoma AJCC v8","longName":"6438069","preferredDefinition":"Stage IIA includes: (T2, N0, M0, G2-3, Tumor location: Any); (T2, N0, M0, GX, Tumor location: Any); (T3, N0, M0, Any G, Tumor location: Lower); (T3, N0, M0, G1, Tumor location: Upper/middle). T2: Tumor invades the muscularis propria. T3: Tumor invades adventitia. N0: No regional lymph node metastasis. M0: No distant metastasis. GX: Grade cannot be assessed. G1: Well-differentiated. G2: Moderately differentiated. G3: Poorly differentiated, undifferentiated. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic Stage IIA Esophageal Squamous Cell Carcinoma AJCC v8","conceptCode":"C133534","definition":"Stage IIA includes: (T2, N0, M0, G2-3, Tumor location: Any); (T2, N0, M0, GX, Tumor location: Any); (T3, N0, M0, Any G, Tumor location: Lower); (T3, N0, M0, G1, Tumor location: Upper/middle). T2: Tumor invades the muscularis propria. T3: Tumor invades adventitia. N0: No regional lymph node metastasis. M0: No distant metastasis. GX: Grade cannot be assessed. G1: Well-differentiated. G2: Moderately differentiated. G3: Poorly differentiated, undifferentiated. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76A20948-DA7B-505B-E053-F662850A72D4","latestVersionIndicator":"Yes","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"ONEDATA","dateModified":"2018-09-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A80D0215-5D00-755C-E053-4EBD850A27CB","beginDate":"2020-06-14","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-06-14","modifiedBy":"ONEDATA","dateModified":"2020-06-14","deletedIndicator":"No"},{"value":"IB-SCC","valueDescription":"Pathologic Stage IB Esophageal Squamous Cell Carcinoma AJCC v8","ValueMeaning":{"publicId":"6438071","version":"1","preferredName":"Pathologic Stage IB Esophageal Squamous Cell Carcinoma AJCC v8","longName":"6438071","preferredDefinition":"Stage IB includes: (T1a, N0, M0, G2-3, Tumor location: Any); (T1b, N0, M0, G1-3, Tumor location: Any); (T1b, N0, M0, GX, Tumor location: Any); (T2, N0, M0, G1, Tumor location: Any). T1a: Tumor invades the lamina propria or muscularis mucosae. T1b: Tumor invades the submucosa. T2: Tumor invades the muscularis propria. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well-differentiated. GX: Grade cannot be assessed. G2: Moderately differentiated. G3: Poorly differentiated, undifferentiated. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic Stage IB Esophageal Squamous Cell Carcinoma AJCC v8","conceptCode":"C133530","definition":"Stage IB includes: (T1a, N0, M0, G2-3, Tumor location: Any); (T1b, N0, M0, G1-3, Tumor location: Any); (T1b, N0, M0, GX, Tumor location: Any); (T2, N0, M0, G1, Tumor location: Any). T1a: Tumor invades the lamina propria or muscularis mucosae. T1b: Tumor invades the submucosa. T2: Tumor invades the muscularis propria. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well-differentiated. GX: Grade cannot be assessed. G2: Moderately differentiated. G3: Poorly differentiated, undifferentiated. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76A20948-DAA1-505B-E053-F662850A72D4","latestVersionIndicator":"Yes","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"ONEDATA","dateModified":"2018-09-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A80D0215-5D14-755C-E053-4EBD850A27CB","beginDate":"2020-06-14","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-06-14","modifiedBy":"ONEDATA","dateModified":"2020-06-14","deletedIndicator":"No"},{"value":"IA-SCC","valueDescription":"Pathologic Stage IA Esophageal Squamous Cell Carcinoma AJCC v8","ValueMeaning":{"publicId":"6438073","version":"1","preferredName":"Pathologic Stage IA Esophageal Squamous Cell Carcinoma AJCC v8","longName":"6438073","preferredDefinition":"Stage IA includes: (T1a, N0, M0, G1, Tumor location: Any); (T1a, N0, M0, GX, Tumor location: Any). T1a: Tumor invades the lamina propria or muscularis mucosae. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well-differentiated. GX: Grade cannot be assessed. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic Stage IA Esophageal Squamous Cell Carcinoma AJCC v8","conceptCode":"C133525","definition":"Stage IA includes: (T1a, N0, M0, G1, Tumor location: Any); (T1a, N0, M0, GX, Tumor location: Any). T1a: Tumor invades the lamina propria or muscularis mucosae. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well-differentiated. GX: Grade cannot be assessed. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76A20948-DAC7-505B-E053-F662850A72D4","latestVersionIndicator":"Yes","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"ONEDATA","dateModified":"2018-09-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A80D0215-5D28-755C-E053-4EBD850A27CB","beginDate":"2020-06-14","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-06-14","modifiedBy":"ONEDATA","dateModified":"2020-06-14","deletedIndicator":"No"},{"value":"0-SCC","valueDescription":"Pathologic Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8","ValueMeaning":{"publicId":"6438075","version":"1","preferredName":"Pathologic Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8","longName":"6438075","preferredDefinition":"Stage 0 includes: Tis, N0, M0, GN/A, Tumor location: Any. Tis: High-grade dysplasia, defined as malignant cells confined to the epithelium by the basement membrane. N0: No regional lymph node metastasis. M0: No distant metastasis. GN/A: Grade non-applicable. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8","conceptCode":"C133519","definition":"Stage 0 includes: Tis, N0, M0, GN/A, Tumor location: Any. Tis: High-grade dysplasia, defined as malignant cells confined to the epithelium by the basement membrane. N0: No regional lymph node metastasis. M0: No distant metastasis. GN/A: Grade non-applicable. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76A20948-DAED-505B-E053-F662850A72D4","latestVersionIndicator":"Yes","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"ONEDATA","dateModified":"2018-09-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A80D0215-5D3C-755C-E053-4EBD850A27CB","beginDate":"2020-06-14","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-06-14","modifiedBy":"ONEDATA","dateModified":"2020-06-14","deletedIndicator":"No"},{"value":"IVB-Adeno","valueDescription":"Pathologic Stage IVB Esophageal Adenocarcinoma AJCC v8","ValueMeaning":{"publicId":"6438023","version":"1","preferredName":"Pathologic Stage IVB Esophageal Adenocarcinoma AJCC v8","longName":"6438023","preferredDefinition":"Stage IVB includes: Any T, Any N, M1, Any G. M1: Distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic Stage IVB Esophageal Adenocarcinoma AJCC v8","conceptCode":"C133426","definition":"Stage IVB includes: Any T, Any N, M1, Any G. M1: Distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76A1BCE8-260D-6076-E053-F662850A7CF3","latestVersionIndicator":"Yes","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"ONEDATA","dateModified":"2018-09-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A80D0215-5D50-755C-E053-4EBD850A27CB","beginDate":"2020-06-14","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-06-14","modifiedBy":"ONEDATA","dateModified":"2020-06-14","deletedIndicator":"No"},{"value":"IVA-Adeno","valueDescription":"Pathologic Stage IVA Esophageal Adenocarcinoma AJCC v8","ValueMeaning":{"publicId":"6438025","version":"1","preferredName":"Pathologic Stage IVA Esophageal Adenocarcinoma AJCC v8","longName":"6438025","preferredDefinition":"Stage IVA includes: (T4a, N2, M0, Any G); (T4b, N0-2, M0, Any G); (Any T, N3, M0, Any G). T4a: Tumor invades the pleura, pericardium, azygos vein, diaphragm, or peritoneum. T4b: Tumor invades other adjacent structures, such as the aorta, vertebral body, or airway. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. N3: Tumor with metastasis in seven or more regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic Stage IVA Esophageal Adenocarcinoma AJCC v8","conceptCode":"C133425","definition":"Stage IVA includes: (T4a, N2, M0, Any G); (T4b, N0-2, M0, Any G); (Any T, N3, M0, Any G). T4a: Tumor invades the pleura, pericardium, azygos vein, diaphragm, or peritoneum. T4b: Tumor invades other adjacent structures, such as the aorta, vertebral body, or airway. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. N3: Tumor with metastasis in seven or more regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76A1BCE8-2633-6076-E053-F662850A7CF3","latestVersionIndicator":"Yes","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"ONEDATA","dateModified":"2018-09-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A80D0215-5D64-755C-E053-4EBD850A27CB","beginDate":"2020-06-14","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-06-14","modifiedBy":"ONEDATA","dateModified":"2020-06-14","deletedIndicator":"No"},{"value":"IIIB-Adeno","valueDescription":"Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8","ValueMeaning":{"publicId":"6438027","version":"1","preferredName":"Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8","longName":"6438027","preferredDefinition":"Stage IIIB includes: (T2, N2, M0, Any G); (T3, N1-2, M0, Any G); (T4a, N0-1, M0, Any G). T2: Tumor invades the muscularis propria. T3: Tumor invades adventitia. T4a: Tumor invades the pleura, pericardium, azygos vein, diaphragm, or peritoneum. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8","conceptCode":"C133423","definition":"Stage IIIB includes: (T2, N2, M0, Any G); (T3, N1-2, M0, Any G); (T4a, N0-1, M0, Any G). T2: Tumor invades the muscularis propria. T3: Tumor invades adventitia. T4a: Tumor invades the pleura, pericardium, azygos vein, diaphragm, or peritoneum. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76A1BCE8-2659-6076-E053-F662850A7CF3","latestVersionIndicator":"Yes","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"ONEDATA","dateModified":"2018-09-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A80D0215-5D78-755C-E053-4EBD850A27CB","beginDate":"2020-06-14","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-06-14","modifiedBy":"ONEDATA","dateModified":"2020-06-14","deletedIndicator":"No"},{"value":"IIIA-Adeno","valueDescription":"Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC v8","ValueMeaning":{"publicId":"6438029","version":"1","preferredName":"Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC v8","longName":"6438029","preferredDefinition":"Stage IIIA includes: (T1, N2, M0, Any G); (T2, N1, M0, Any G). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC v8","conceptCode":"C133422","definition":"Stage IIIA includes: (T1, N2, M0, Any G); (T2, N1, M0, Any G). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76A1BCE8-267F-6076-E053-F662850A7CF3","latestVersionIndicator":"Yes","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"ONEDATA","dateModified":"2018-09-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A80D0215-5D8C-755C-E053-4EBD850A27CB","beginDate":"2020-06-14","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-06-14","modifiedBy":"ONEDATA","dateModified":"2020-06-14","deletedIndicator":"No"},{"value":"IIB-Adeno","valueDescription":"Pathologic Stage IIB Esophageal Adenocarcinoma AJCC v8","ValueMeaning":{"publicId":"6438031","version":"1","preferredName":"Pathologic Stage IIB Esophageal Adenocarcinoma AJCC v8","longName":"6438031","preferredDefinition":"Stage IIB includes: (T1, N1, M0, Any G); (T3, N0, M0, Any G). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T3: Tumor invades adventitia. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic Stage IIB Esophageal Adenocarcinoma AJCC v8","conceptCode":"C133420","definition":"Stage IIB includes: (T1, N1, M0, Any G); (T3, N0, M0, Any G). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T3: Tumor invades adventitia. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76A1BCE8-26A5-6076-E053-F662850A7CF3","latestVersionIndicator":"Yes","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"ONEDATA","dateModified":"2018-09-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A80D0215-5DA0-755C-E053-4EBD850A27CB","beginDate":"2020-06-14","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-06-14","modifiedBy":"ONEDATA","dateModified":"2020-06-14","deletedIndicator":"No"},{"value":"IIA-Adeno","valueDescription":"Pathologic Stage IIA Esophageal Adenocarcinoma AJCC v8","ValueMeaning":{"publicId":"6438033","version":"1","preferredName":"Pathologic Stage IIA Esophageal Adenocarcinoma AJCC v8","longName":"6438033","preferredDefinition":"Stage IIA includes: (T2, N0, M0, G3); (T2, N0, M0, GX). T2: Tumor invades the muscularis propria. N0: No regional lymph node metastasis. M0: No distant metastasis. GX: Grade cannot be assessed. G3: Poorly differentiated, undifferentiated. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic Stage IIA Esophageal Adenocarcinoma AJCC v8","conceptCode":"C133419","definition":"Stage IIA includes: (T2, N0, M0, G3); (T2, N0, M0, GX). T2: Tumor invades the muscularis propria. N0: No regional lymph node metastasis. M0: No distant metastasis. GX: Grade cannot be assessed. G3: Poorly differentiated, undifferentiated. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76A1BCE8-26CB-6076-E053-F662850A7CF3","latestVersionIndicator":"Yes","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"ONEDATA","dateModified":"2018-09-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A80D0215-5DB4-755C-E053-4EBD850A27CB","beginDate":"2020-06-14","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-06-14","modifiedBy":"ONEDATA","dateModified":"2020-06-14","deletedIndicator":"No"},{"value":"IC-Adeno","valueDescription":"Pathologic Stage IC Esophageal Adenocarcinoma AJCC v8","ValueMeaning":{"publicId":"6438035","version":"1","preferredName":"Pathologic Stage IC Esophageal Adenocarcinoma AJCC v8","longName":"6438035","preferredDefinition":"Stage IC includes: (T1, N0, M0, G3); (T2, N0, M0, G1-2). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well-differentiated. G2: Moderately differentiated. G3: Poorly differentiated, undifferentiated. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic Stage IC Esophageal Adenocarcinoma AJCC v8","conceptCode":"C133417","definition":"Stage IC includes: (T1, N0, M0, G3); (T2, N0, M0, G1-2). T1: Tumor invades the lamina propria, muscularis mucosae, or submucosa. T2: Tumor invades the muscularis propria. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well-differentiated. G2: Moderately differentiated. G3: Poorly differentiated, undifferentiated. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76A1BCE8-26F1-6076-E053-F662850A7CF3","latestVersionIndicator":"Yes","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"ONEDATA","dateModified":"2018-09-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A80D0215-5DC8-755C-E053-4EBD850A27CB","beginDate":"2020-06-14","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-06-14","modifiedBy":"ONEDATA","dateModified":"2020-06-14","deletedIndicator":"No"},{"value":"IB-Adeno","valueDescription":"Pathologic Stage IB Esophageal Adenocarcinoma AJCC v8","ValueMeaning":{"publicId":"6437999","version":"1","preferredName":"Pathologic Stage IB Esophageal Adenocarcinoma AJCC v8","longName":"6437999","preferredDefinition":"Stage IB includes: (T1a, N0, M0, G2); (T1b, N0, M0, G1-2); (T1b, N0, M0, GX). T1a: Tumor invades the lamina propria or muscularis mucosae. T1b: Tumor invades the submucosa. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well-differentiated. GX: Grade cannot be assessed. G2: Moderately differentiated. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic Stage IB Esophageal Adenocarcinoma AJCC v8","conceptCode":"C133416","definition":"Stage IB includes: (T1a, N0, M0, G2); (T1b, N0, M0, G1-2); (T1b, N0, M0, GX). T1a: Tumor invades the lamina propria or muscularis mucosae. T1b: Tumor invades the submucosa. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well-differentiated. GX: Grade cannot be assessed. G2: Moderately differentiated. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76A01FE5-A3F1-3B21-E053-F662850A2F2A","latestVersionIndicator":"Yes","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"ONEDATA","dateModified":"2018-09-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A80D0215-5DDC-755C-E053-4EBD850A27CB","beginDate":"2020-06-14","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-06-14","modifiedBy":"ONEDATA","dateModified":"2020-06-14","deletedIndicator":"No"},{"value":"IA-Adeno","valueDescription":"Pathologic Stage IA Esophageal Adenocarcinoma AJCC v8","ValueMeaning":{"publicId":"6438001","version":"1","preferredName":"Pathologic Stage IA Esophageal Adenocarcinoma AJCC v8","longName":"6438001","preferredDefinition":"Stage IA includes: (T1a, N0, M0, G1); (T1a, N0, M0, GX). T1a: Tumor invades the lamina propria or muscularis mucosae. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well-differentiated. GX: Grade cannot be assessed. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic Stage IA Esophageal Adenocarcinoma AJCC v8","conceptCode":"C133415","definition":"Stage IA includes: (T1a, N0, M0, G1); (T1a, N0, M0, GX). T1a: Tumor invades the lamina propria or muscularis mucosae. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well-differentiated. GX: Grade cannot be assessed. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76A01FE5-A417-3B21-E053-F662850A2F2A","latestVersionIndicator":"Yes","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"ONEDATA","dateModified":"2018-09-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A80D0215-5DF0-755C-E053-4EBD850A27CB","beginDate":"2020-06-14","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-06-14","modifiedBy":"ONEDATA","dateModified":"2020-06-14","deletedIndicator":"No"},{"value":"0-Adeno","valueDescription":"Pathologic Stage 0 Esophageal Adenocarcinoma AJCC v8","ValueMeaning":{"publicId":"6438003","version":"1","preferredName":"Pathologic Stage 0 Esophageal Adenocarcinoma AJCC v8","longName":"6438003","preferredDefinition":"Stage 0 includes: Tis, N0, M0, GN/A. Tis: High-grade dysplasia, defined as malignant cells confined to the epithelium by the basement membrane. N0: No regional lymph node metastasis. M0: No distant metastasis. GN/A: Grade non-applicable. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic Stage 0 Esophageal Adenocarcinoma AJCC v8","conceptCode":"C133413","definition":"Stage 0 includes: Tis, N0, M0, GN/A. Tis: High-grade dysplasia, defined as malignant cells confined to the epithelium by the basement membrane. N0: No regional lymph node metastasis. M0: No distant metastasis. GN/A: Grade non-applicable. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76A01FE5-A43D-3B21-E053-F662850A2F2A","latestVersionIndicator":"Yes","beginDate":"2018-09-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-09-24","modifiedBy":"ONEDATA","dateModified":"2018-09-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A80D0215-5E04-755C-E053-4EBD850A27CB","beginDate":"2020-06-14","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-06-14","modifiedBy":"ONEDATA","dateModified":"2020-06-14","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7331797","version":"1","preferredName":"Clinical Proteomic Tumor Analysis Consortium Esophageal Neoplasm Stage","preferredDefinition":"A national effort to accelerate the understanding of the molecular basis of cancer through the application of large-scale proteome and genome analysis, or proteogenomics.:A benign or malignant neoplasm involving the esophagus.:The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"C157175:C3028:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Proteomic Tumor Analysis Consortium","conceptCode":"C157175","definition":"A national effort to accelerate the understanding of the molecular basis of cancer through the application of large-scale proteome and genome analysis, or proteogenomics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Esophageal Neoplasm","conceptCode":"C3028","definition":"A benign or malignant neoplasm involving the esophagus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A80D0215-5C6A-755C-E053-4EBD850A27CB","latestVersionIndicator":"Yes","beginDate":"2020-06-14","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-06-14","modifiedBy":"ONEDATA","dateModified":"2020-06-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A80D0215-5C7B-755C-E053-4EBD850A27CB","latestVersionIndicator":"Yes","beginDate":"2020-06-14","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-06-14","modifiedBy":"KNABLEJ","dateModified":"2020-06-22","changeDescription":"6/22/20 jk Released per SME (NGM) review and approval email.   5/12/20 jk created for CPTAC unique ESCA stage question which combines AJCC subtype responses; VD uses AJCC terms/definitions.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6601273","version":"1","longName":"CPTAC (Clinical Proteomic Tumor Analysis Consortium)","context":"OCCPR","ClassificationSchemeItems":[{"publicId":"6601282","version":"1","longName":"Esophagus","context":"OCCPR"},{"publicId":"6779553","version":"1","longName":"ESCA Baseline","context":"OCCPR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Tumor Stage (Pathologic)","type":"Preferred Question Text","description":"Tumor Stage (Pathologic)","url":null,"context":"OCCPR"}],"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A7E59FD9-18B3-4319-E053-4EBD850A29CE","latestVersionIndicator":"Yes","beginDate":"2020-06-12","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-06-12","modifiedBy":"KNABLEJ","dateModified":"2020-06-22","changeDescription":"6/22/20 jk Released per SME (NGM) review and approval email.  6/14/20 jk upd VD adding histologic type to PV.  6/12/20 jk created for CPTAC ESCA Baseline CRF - generalized AJCC 3 subtype levels.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}